SCHEMBL6357975

SCHEMBL6357975

Cc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)NC1Cc2ccccc2C1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.64
KMT2A Q03164 5/20 0.64
RPA1 P27694 2/20 0.59
GFER P55789 1/20 0.59
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
TP53 P04637 4/20 0.50
MAPT P10636 4/20 0.50
NPC1 O15118 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
AKR1C2 P52895 2/20 0.48
AKR1C1 Q04828 2/20 0.48
AKR1C4 P17516 1/20 0.48
AKR1C3 P42330 1/20 0.48
PPARG P37231 1/20 0.48
PPARD Q03181 1/20 0.48
PPARA Q07869 1/20 0.48
PTGES O14684 1/20 0.46
ALOX5 P09917 1/20 0.46
DHODH Q02127 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355358 0.91 MEN1 (0.53) MEN1KMT2ARPA1GFERALDH1A1
SCHEMBL6352363 0.88 MAPT (0.52) MEN1KMT2ARPA1GFERALDH1A1
SCHEMBL6351288 0.85 PPARG (0.52) MEN1KMT2ATP53MAPTAKR1C2
SCHEMBL6353643 0.84 LMNA (0.49) MEN1KMT2ARPA1GFERTP53
SCHEMBL6350870 0.84 PPARG (0.61) MEN1KMT2ATP53MAPTAKR1C2
SCHEMBL6833903 0.83 MEN1 (0.42) MEN1KMT2ARPA1GFERMAPT
SCHEMBL6834099 0.82 PRSS12 (0.42) MEN1KMT2ARPA1GFERMAPT
SCHEMBL6833361 0.81 PPARG (0.49) MEN1KMT2ARPA1GFERMAPT
SCHEMBL6351026 0.78 LMNA (0.51) MEN1KMT2ATP53MAPTAKR1C2
SCHEMBL13870904 0.78 MEN1 (1.00) MEN1KMT2ARPA1GFERKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MEN1 3274/4885KMT2A 3645/4885RPA1 3847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.